Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial - Wikidata - wikimedia - TriplyDB

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

http://www.wikidata.org/entity/Q28383260

about

Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer.Evaluation of astrocytoma cell proliferation using diffusion-weighted imaging: correlation with expression of proliferating cell nuclear antigen.Screening and Identification of APOC1 as a Novel Potential Biomarker for Differentiate of Mycoplasma pneumoniae in Children.Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer.Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

P2860

Q36707857-C0424313-E822-4692-9E55-B0A6C46B085D Q37074603-D09E0DE9-105C-4815-A89A-7A374301F285 Q37504304-5862F811-8D1F-47C4-A0B1-5C876D642066 Q47392724-134D3D19-3888-4F4D-92D5-13C7D8B78DDC Q54965847-F66F0229-1C2C-4E94-971F-3A27C03F0184

P2860

Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

http://www.wikidata.org/entity/Q28383260

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@ast

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@en

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@nl

type

label

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@ast

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@en

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@nl

prefLabel

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@ast

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@en

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@nl

P1433

Q28383260-A9E8972B-E25B-4426-9A0F-13C47E6437E4

P1476

Q28383260-B658FFB4-8D72-42B0-9EEC-21B228B00247

P2093

Q28383260-2324BCAD-829B-47C7-9CC0-58E947C9054A

Q28383260-3DF6712C-F022-4DD5-86B7-C15C88539EDB

Q28383260-90C9FA8E-237C-49B6-BC82-DD19ED73FB70

Q28383260-A0113412-FCCF-4A23-A6FB-086C81A8DD4C

Q28383260-AE01D5EF-6258-44EA-BAF7-50553C12AFCF

Q28383260-DB51AF8E-537E-4228-A54B-A285CDA96131

P2860

Q28383260-0004AA3C-111C-4F47-8998-965375C99C87

Q28383260-035DBEE7-B393-4B65-8005-C9BBBDB5137F

Q28383260-075229F2-7766-44D7-B2D9-6521DA549562

Q28383260-1732E461-7AE4-42EF-9CF8-449A0B0CCD0F

Q28383260-1AC46F33-D521-4BCF-A7C7-CCC0C5B14F85

Q28383260-1AF456AF-7DBE-4F4A-BA38-48B5BD22FE75

Q28383260-2386E6D6-A07D-4E32-AA15-7F900531AB88

Q28383260-243AE656-0FB3-4914-B23A-ACA2ACE1D5A1

Q28383260-2AFE9F67-0FCB-4EB0-81ED-7CB9FDB2AAFC

Q28383260-2B958E6C-F8A6-4E38-ACA1-8C94990FA5B2

P304

Q28383260-2DC5458C-28C4-4BCB-873F-E03C9AD3EDE8

P31

Q28383260-61F84BAA-4879-4A41-AA71-6B51E106669A

P3181

Q28383260-C17E0A5F-ECE8-4EEE-BCB6-55651F99D79E

P356

Q28383260-DE0BD43B-4750-4487-B4B0-E0771D4331EB

P407

Q28383260-28499989-3229-48A4-ABEA-1B766F908B86

P433

Q28383260-0EF5D506-3F64-4EC3-8EAB-0FBB38C9C43E

P478

Q28383260-1180DC4E-F921-4C88-AEEE-A8299765151C

P577

Q28383260-36D408E7-899F-40D1-AF15-63935BEBF478

P5875

Q28383260-CF4A9103-E41C-49BD-BA05-2B06408ED458

P698

Q28383260-6F70E526-56DA-4293-B1B6-7CE7EF9179E5

P921

Q28383260-1E954EB9-B261-49D2-8787-E47023D62D92

Q28383260-22E2E595-9E92-4AC9-8FAD-416D4260982C

P932

Q28383260-B68F7C84-3B14-48E7-8F6B-7E5D72EBC310

P3181

P356

1759-7714.12117

P1433

Thoracic Cancer

P1476

Apolipoprotein C1 (APOC1) as a ...... cancer: A marker phase I trial

@en

P2093

Hui-Ling Ko

http://www.w3.org/2001/XMLSchema#string

Kwan-Hwa Chi

http://www.w3.org/2001/XMLSchema#string

Mau-Shin Chi

http://www.w3.org/2001/XMLSchema#string

Shang-Jyh Kao

http://www.w3.org/2001/XMLSchema#string

Weng-Lam Fong

http://www.w3.org/2001/XMLSchema#string

Yu-Shan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of gene expression-based prediction of survival in non-small cell lung cancer

Thf complete amino acid sequence of C-I (apoLp-Ser), an apolipoprotein from human very low density lipoproteins

Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene

Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices

Cancer statistics, 2009

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.

Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.

Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.

P304

500-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1960495

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/1759-7714.12117

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261330998

http://www.w3.org/2001/XMLSchema#string

P698

26767044

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

4704334

http://www.w3.org/2001/XMLSchema#string